Financial Performance - For the first quarter of 2024, the company's unaudited consolidated revenue was HKD 2,398.67 million, an increase of 3.0% compared to HKD 2,329.72 million in the same period last year[3]. - The company's unaudited consolidated operating profit for the first quarter of 2024 was HKD 51.25 million, a decrease of 5.5% from HKD 54.23 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders for the first quarter of 2024 was HKD 9.65 million, down 41.1% from HKD 16.37 million in the same period last year[3]. Asset Management - Total assets as of March 31, 2024, were HKD 4,649.09 million, a decrease of 2.9% from HKD 4,789.00 million at the end of December 2023[3]. Business Segments - The food biological business generated revenue of HKD 1,942.00 million in the first quarter of 2024, an increase of 8.7% year-on-year, with a market share of approximately 49% in the live pig market in Hong Kong[7]. - The live pig slaughter volume exceeded 760,000 heads in the first quarter of 2024, representing a year-on-year increase of 16.4%[7]. - The tinplate business produced 69,000 tons of products in the first quarter of 2024, an increase of 9.5% year-on-year, but sales decreased by 4.5% to 63,000 tons[9]. - Revenue from the tinplate business was HKD 453.00 million, a decrease of 16.0% compared to the same period last year, with segment profit down 75.7%[9]. Valuation and Challenges - The company recorded an investment property valuation loss of HKD 0.84 million in the current period, whereas there was no valuation loss in the same period last year[10]. - The company anticipates ongoing challenges in the food biological business due to falling pig prices and fluctuations in demand and raw material prices in the tinplate business[11].
广南(集团)(01203) - 2024 Q1 - 季度业绩